TARGETING BET FAMILY PROTEINS IMPROVES THE THERAPEUTIC EFFICACY OF BCL-2 INHIBITION IN T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA

被引：0

作者：

Peirs, S. ^{[1
]}

Frismantas, V. ^{[2
]}

Matthijssens, F. ^{[1
]}

Lintermans, B. ^{[1
]}

Pieters, T. ^{[1
,3
,4
]}

Vandamme, N. ^{[3
,4
]}

Van Loocke, W. ^{[1
]}

Berx, G. ^{[3
,4
]}

Poppe, B. ^{[1
]}

Bourquin, J. P. ^{[2
]}

Van Vlierberghe, P. ^{[1
]}

机构：

[1] Univ Ghent, Ctr Med Genet Ghent, Ghent, Belgium

[2] Univ Childrens Hosp Zurich, Childrens Res Ctr, Pediat Oncol, Zurich, Switzerland

[3] Univ Ghent, Unit Mol & Cellular Oncol, VIB Inflammat Res Ctr, Ghent, Belgium

[4] Univ Ghent, Dept Biomed Mol Biol, Ghent, Belgium

来源：

HAEMATOLOGICA | 2016年 / 101卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

P536

引用

页码：201 / 202

页数：2

共 50 条

[41] Bcl-2 Family Proteins as Therapeutic Targets
Czabotar, Peter E.
Lessene, Guillaume
CURRENT PHARMACEUTICAL DESIGN, 2010, 16 (28) : 3132 - 3148
[42] Inhibition of the JAK/STAT and Bcl-2 Pathways Enhances Anti-Tumor Effects in an in Vitro model of T-Cell Acute Lymphoblastic Leukemia (T-ALL)
Gavcovich, Tara Bree
Walker, Kirsti Lorraine
Bouchlaka, Myriam N.
Capitini, Christian M.
BLOOD, 2015, 126 (23)
[43] T-cell acute lymphoblastic leukemia
Raetz, Elizabeth A.
Teachey, David T.
HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM, 2016, : 580 - 588
[44] T-cell acute lymphoblastic leukemia
Chiaretti, Sabina
Foa, Robin
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 (02): : 160 - 162
[45] Targeting IRAK1 in T-Cell acute lymphoblastic leukemia
Dussiau, Charles
Trinquand, Amelie
Lhermitte, Ludovic
Latiri, Mehdi
Simonin, Mathieu
Cieslak, Agata
Bedjaoui, Nawel
Villarese, Patrick
Verhoeyen, Els
Dombret, Herve
Ifrah, Norbert
Macintyre, Elizabeth
Asnafi, Vahid
ONCOTARGET, 2015, 6 (22) : 18956 - 18965
[46] Targeting serine hydroxymethyltransferases 1 and 2 for T-cell acute lymphoblastic leukemia therapy
Yana Pikman
Nicole Ocasio-Martinez
Gabriela Alexe
Boris Dimitrov
Samuel Kitara
Frances F. Diehl
Amanda L. Robichaud
Amy Saur Conway
Linda Ross
Angela Su
Frank Ling
Jun Qi
Giovanni Roti
Caroline A. Lewis
Alexandre Puissant
Matthew G. Vander Heiden
Kimberly Stegmaier
Leukemia, 2022, 36 : 348 - 360
[47] Targeting serine hydroxymethyltransferases 1 and 2 for T-cell acute lymphoblastic leukemia therapy
Pikman, Yana
Ocasio-Martinez, Nicole
Alexe, Gabriela
Dimitrov, Boris
Kitara, Samuel
Diehl, Frances F.
Robichaud, Amanda L.
Conway, Amy Saur
Ross, Linda
Su, Angela
Ling, Frank
Qi, Jun
Roti, Giovanni
Lewis, Caroline A.
Puissant, Alexandre
Vander Heiden, Matthew G.
Stegmaier, Kimberly
LEUKEMIA, 2022, 36 (02) : 348 - 360
[48] Bcl-2 inhibition of T-cell proliferation is related to prolonged T-cell survival
Cheng, NL
Janumyan, YM
Didion, L
Van Hofwegen, C
Yang, E
Knudson, CM
ONCOGENE, 2004, 23 (21) : 3770 - 3780
[49] Bcl-2 inhibition of T-cell proliferation is related to prolonged T-cell survival
Ningli Cheng
Yelena M Janumyan
Lisa Didion
Chris Van Hofwegen
Elizabeth Yang
C Michael Knudson
Oncogene, 2004, 23 : 3770 - 3780
[50] BCL11B Mutations In T-Cell Acute Lymphoblastic Leukemia
Keersmaecker, Kim De
Jose Real, Pedro
Della Gatta, Giusy
Palomero, Teresa
Sulis, Maria Luisa
Tosello, Valeria
Van Vlierberghe, Pieter
Barnes, Kelly
Castillo, Mireia
Sole, Xavier
Hadler, Michael
Lenz, Jack
Aplan, Peter
Kelliher, Michelle
Kee, Barbara L.
Pandolfi, Pier Paolo
Kappes, Dietmar
Gounari, Fotini
Petrie, Howard
Van der Meulen, Joni
Speleman, Frank
Paietta, Elisabeth
Racevskis, Janis
Tallman, Martin
Rowe, Jacob M.
Soulier, Jean
Avran, David
Cave, Helene
Dastugue, Nicole
Raimondi, Susana C.
Meijerink, Jules
Cordon-Cardo, Carlos
Califano, Andrea
Ferrando, Adolfo
BLOOD, 2010, 116 (21) : 210 - 210

← 1 2 3 4 5 →